Last updated on June 2019

Clinical Trial to Evaluate the Efficacy Safety and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy


Brief description of study

This is a multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability of two different weekly doses of RO7239361 in ambulatory boys with Duchenne Muscular Dystrophy (DMD).

Clinical Study Identifier: NCT03039686

Find a site near you

Start Over

Instituto centenario

Buenos Aires, Argentina
  Connect »